Balyasny Asset Management’s Innate Pharma IPHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,094	Closed	-$32K	–	2515
2022 Q3	$32K	Buy	+16,094	New	+$32K	﹤0.01%	2039
2021 Q4	–	Sell	-187,484	Closed	-$1.16M	–	2155
2021 Q3	$1.16M	Buy	+187,484	New	+$1.16M	﹤0.01%	1082